The pharmaceutical giant is now considered one of Morningstar's highest-conviction undervalued stocks, citing a robust pipeline and strategic acquisitions.
Strategic acquisition aims to bolster Firefly's national security and defense capabilities, expanding its space and defense mission services.
The combination creates the 4th largest US wafer fabrication equipment supplier, targeting an expanded $5 billion market.
Institutional demand and economic uncertainty fuel the historic rally in the world's largest cryptocurrency, pushing the market into a bullish frenzy.
Pharmaceuticals, heavy trucks, and furniture targeted in a move that could spark fresh inflation fears and impact corporate profits.
Final regulatory hurdle cleared for the all-stock transaction, paving the way for an October 20 closing and a major expansion into Texas.
The ongoing US government shutdown is delaying critical jobs and inflation reports, creating an information vacuum for investors and the Federal Reserve.
Shares fall despite strong Q3 sales, as expiring EV tax credits and valuation concerns spook investors.